 | • レポートコード：QYR2104Z1488 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、眼科一般用医薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他）、用途別市場規模（ドライアイ、緑内障、感染症/炎症、網膜障害、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・眼科一般用医薬品の市場動向 ・企業の競争状況、市場シェア ・眼科一般用医薬品の種類別市場規模（抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他） ・眼科一般用医薬品の用途別市場規模（ドライアイ、緑内障、感染症/炎症、網膜障害、その他） ・眼科一般用医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・眼科一般用医薬品のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・眼科一般用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・眼科一般用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・眼科一般用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Novartis、Bausch Health、Fresenius、Teva Pharmaceutical、Allergan、Mylan、Santen Pharmaceutical、Takeda、Johnson & Johnson、APOTEX、GE Medical、Jamp Pharma、Senju Pharmaceutical、Chongqing Chemical & Pharmaceutical Holding (Group) Company、Sun Pharmaceutical、Taj Pharmaceuticals） ・結論 |
Market Analysis and Insights: Global Common Drugs Use in Ophthalmology Market
The global Common Drugs Use in Ophthalmology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Common Drugs Use in Ophthalmology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Common Drugs Use in Ophthalmology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Common Drugs Use in Ophthalmology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Common Drugs Use in Ophthalmology market.
Global Common Drugs Use in Ophthalmology Scope and Market Size
Common Drugs Use in Ophthalmology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Common Drugs Use in Ophthalmology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others
Segment by Application
Dry Eye
Glaucoma
Infection/Inflammation
Retinal Disorders
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Novartis
Bausch Health
Fresenius
Teva Pharmaceutical
Allergan
Mylan
Santen Pharmaceutical
Takeda
Johnson & Johnson
APOTEX
GE Medical
Jamp Pharma
Senju Pharmaceutical
Chongqing Chemical & Pharmaceutical Holding (Group) Company
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Common Drugs Use in Ophthalmology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-inflammatory Drugs
1.2.3 Anti-infective Drugs
1.2.4 Anti-glaucoma Drugs
1.2.5 Anti-allergy Drugs
1.2.6 Anti-VEGF Agents
1.2.7 Others
1.3 Market by Application
1.3.1 Global Common Drugs Use in Ophthalmology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dry Eye
1.3.3 Glaucoma
1.3.4 Infection/Inflammation
1.3.5 Retinal Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Common Drugs Use in Ophthalmology Market Perspective (2016-2027)
2.2 Common Drugs Use in Ophthalmology Growth Trends by Regions
2.2.1 Common Drugs Use in Ophthalmology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Common Drugs Use in Ophthalmology Historic Market Share by Regions (2016-2021)
2.2.3 Common Drugs Use in Ophthalmology Forecasted Market Size by Regions (2022-2027)
2.3 Common Drugs Use in Ophthalmology Industry Dynamic
2.3.1 Common Drugs Use in Ophthalmology Market Trends
2.3.2 Common Drugs Use in Ophthalmology Market Drivers
2.3.3 Common Drugs Use in Ophthalmology Market Challenges
2.3.4 Common Drugs Use in Ophthalmology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Common Drugs Use in Ophthalmology Players by Revenue
3.1.1 Global Top Common Drugs Use in Ophthalmology Players by Revenue (2016-2021)
3.1.2 Global Common Drugs Use in Ophthalmology Revenue Market Share by Players (2016-2021)
3.2 Global Common Drugs Use in Ophthalmology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Common Drugs Use in Ophthalmology Revenue
3.4 Global Common Drugs Use in Ophthalmology Market Concentration Ratio
3.4.1 Global Common Drugs Use in Ophthalmology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Common Drugs Use in Ophthalmology Revenue in 2020
3.5 Common Drugs Use in Ophthalmology Key Players Head office and Area Served
3.6 Key Players Common Drugs Use in Ophthalmology Product Solution and Service
3.7 Date of Enter into Common Drugs Use in Ophthalmology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Common Drugs Use in Ophthalmology Breakdown Data by Type
4.1 Global Common Drugs Use in Ophthalmology Historic Market Size by Type (2016-2021)
4.2 Global Common Drugs Use in Ophthalmology Forecasted Market Size by Type (2022-2027)
5 Common Drugs Use in Ophthalmology Breakdown Data by Application
5.1 Global Common Drugs Use in Ophthalmology Historic Market Size by Application (2016-2021)
5.2 Global Common Drugs Use in Ophthalmology Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Common Drugs Use in Ophthalmology Market Size (2016-2027)
6.2 North America Common Drugs Use in Ophthalmology Market Size by Type
6.2.1 North America Common Drugs Use in Ophthalmology Market Size by Type (2016-2021)
6.2.2 North America Common Drugs Use in Ophthalmology Market Size by Type (2022-2027)
6.2.3 North America Common Drugs Use in Ophthalmology Market Size by Type (2016-2027)
6.3 North America Common Drugs Use in Ophthalmology Market Size by Application
6.3.1 North America Common Drugs Use in Ophthalmology Market Size by Application (2016-2021)
6.3.2 North America Common Drugs Use in Ophthalmology Market Size by Application (2022-2027)
6.3.3 North America Common Drugs Use in Ophthalmology Market Size by Application (2016-2027)
6.4 North America Common Drugs Use in Ophthalmology Market Size by Country
6.4.1 North America Common Drugs Use in Ophthalmology Market Size by Country (2016-2021)
6.4.2 North America Common Drugs Use in Ophthalmology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Common Drugs Use in Ophthalmology Market Size (2016-2027)
7.2 Europe Common Drugs Use in Ophthalmology Market Size by Type
7.2.1 Europe Common Drugs Use in Ophthalmology Market Size by Type (2016-2021)
7.2.2 Europe Common Drugs Use in Ophthalmology Market Size by Type (2022-2027)
7.2.3 Europe Common Drugs Use in Ophthalmology Market Size by Type (2016-2027)
7.3 Europe Common Drugs Use in Ophthalmology Market Size by Application
7.3.1 Europe Common Drugs Use in Ophthalmology Market Size by Application (2016-2021)
7.3.2 Europe Common Drugs Use in Ophthalmology Market Size by Application (2022-2027)
7.3.3 Europe Common Drugs Use in Ophthalmology Market Size by Application (2016-2027)
7.4 Europe Common Drugs Use in Ophthalmology Market Size by Country
7.4.1 Europe Common Drugs Use in Ophthalmology Market Size by Country (2016-2021)
7.4.2 Europe Common Drugs Use in Ophthalmology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Common Drugs Use in Ophthalmology Market Size (2016-2027)
8.2 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Type
8.2.1 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Type (2016-2027)
8.3 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Application
8.3.1 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Application (2016-2027)
8.4 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Region
8.4.1 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Common Drugs Use in Ophthalmology Market Size (2016-2027)
9.2 Latin America Common Drugs Use in Ophthalmology Market Size by Type
9.2.1 Latin America Common Drugs Use in Ophthalmology Market Size by Type (2016-2021)
9.2.2 Latin America Common Drugs Use in Ophthalmology Market Size by Type (2022-2027)
9.2.3 Latin America Common Drugs Use in Ophthalmology Market Size by Type (2016-2027)
9.3 Latin America Common Drugs Use in Ophthalmology Market Size by Application
9.3.1 Latin America Common Drugs Use in Ophthalmology Market Size by Application (2016-2021)
9.3.2 Latin America Common Drugs Use in Ophthalmology Market Size by Application (2022-2027)
9.3.3 Latin America Common Drugs Use in Ophthalmology Market Size by Application (2016-2027)
9.4 Latin America Common Drugs Use in Ophthalmology Market Size by Country
9.4.1 Latin America Common Drugs Use in Ophthalmology Market Size by Country (2016-2021)
9.4.2 Latin America Common Drugs Use in Ophthalmology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Common Drugs Use in Ophthalmology Market Size (2016-2027)
10.2 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Type
10.2.1 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Type (2016-2027)
10.3 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Application
10.3.1 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Application (2016-2027)
10.4 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Country
10.4.1 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Common Drugs Use in Ophthalmology Introduction
11.1.4 Pfizer Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Common Drugs Use in Ophthalmology Introduction
11.2.4 Novartis Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Common Drugs Use in Ophthalmology Introduction
11.3.4 Bausch Health Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.3.5 Bausch Health Recent Development
11.4 Fresenius
11.4.1 Fresenius Company Details
11.4.2 Fresenius Business Overview
11.4.3 Fresenius Common Drugs Use in Ophthalmology Introduction
11.4.4 Fresenius Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.4.5 Fresenius Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Details
11.5.2 Teva Pharmaceutical Business Overview
11.5.3 Teva Pharmaceutical Common Drugs Use in Ophthalmology Introduction
11.5.4 Teva Pharmaceutical Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.5.5 Teva Pharmaceutical Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Common Drugs Use in Ophthalmology Introduction
11.6.4 Allergan Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.6.5 Allergan Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Common Drugs Use in Ophthalmology Introduction
11.7.4 Mylan Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Santen Pharmaceutical
11.8.1 Santen Pharmaceutical Company Details
11.8.2 Santen Pharmaceutical Business Overview
11.8.3 Santen Pharmaceutical Common Drugs Use in Ophthalmology Introduction
11.8.4 Santen Pharmaceutical Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.8.5 Santen Pharmaceutical Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Common Drugs Use in Ophthalmology Introduction
11.9.4 Takeda Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.9.5 Takeda Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Common Drugs Use in Ophthalmology Introduction
11.10.4 Johnson & Johnson Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 APOTEX
11.11.1 APOTEX Company Details
11.11.2 APOTEX Business Overview
11.11.3 APOTEX Common Drugs Use in Ophthalmology Introduction
11.11.4 APOTEX Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.11.5 APOTEX Recent Development
11.12 GE Medical
11.12.1 GE Medical Company Details
11.12.2 GE Medical Business Overview
11.12.3 GE Medical Common Drugs Use in Ophthalmology Introduction
11.12.4 GE Medical Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.12.5 GE Medical Recent Development
11.13 Jamp Pharma
11.13.1 Jamp Pharma Company Details
11.13.2 Jamp Pharma Business Overview
11.13.3 Jamp Pharma Common Drugs Use in Ophthalmology Introduction
11.13.4 Jamp Pharma Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.13.5 Jamp Pharma Recent Development
11.14 Senju Pharmaceutical
11.14.1 Senju Pharmaceutical Company Details
11.14.2 Senju Pharmaceutical Business Overview
11.14.3 Senju Pharmaceutical Common Drugs Use in Ophthalmology Introduction
11.14.4 Senju Pharmaceutical Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.14.5 Senju Pharmaceutical Recent Development
11.15 Chongqing Chemical & Pharmaceutical Holding (Group) Company
11.15.1 Chongqing Chemical & Pharmaceutical Holding (Group) Company Company Details
11.15.2 Chongqing Chemical & Pharmaceutical Holding (Group) Company Business Overview
11.15.3 Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Introduction
11.15.4 Chongqing Chemical & Pharmaceutical Holding (Group) Company Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.15.5 Chongqing Chemical & Pharmaceutical Holding (Group) Company Recent Development
11.16 Sun Pharmaceutical
11.16.1 Sun Pharmaceutical Company Details
11.16.2 Sun Pharmaceutical Business Overview
11.16.3 Sun Pharmaceutical Common Drugs Use in Ophthalmology Introduction
11.16.4 Sun Pharmaceutical Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.16.5 Sun Pharmaceutical Recent Development
11.17 Taj Pharmaceuticals
11.17.1 Taj Pharmaceuticals Company Details
11.17.2 Taj Pharmaceuticals Business Overview
11.17.3 Taj Pharmaceuticals Common Drugs Use in Ophthalmology Introduction
11.17.4 Taj Pharmaceuticals Revenue in Common Drugs Use in Ophthalmology Business (2016-2021)
11.17.5 Taj Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Common Drugs Use in Ophthalmology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-inflammatory Drugs
Table 3. Key Players of Anti-infective Drugs
Table 4. Key Players of Anti-glaucoma Drugs
Table 5. Key Players of Anti-allergy Drugs
Table 6. Key Players of Anti-VEGF Agents
Table 7. Key Players of Others
Table 8. Global Common Drugs Use in Ophthalmology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Common Drugs Use in Ophthalmology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Common Drugs Use in Ophthalmology Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Common Drugs Use in Ophthalmology Market Share by Regions (2016-2021)
Table 12. Global Common Drugs Use in Ophthalmology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Common Drugs Use in Ophthalmology Market Share by Regions (2022-2027)
Table 14. Common Drugs Use in Ophthalmology Market Trends
Table 15. Common Drugs Use in Ophthalmology Market Drivers
Table 16. Common Drugs Use in Ophthalmology Market Challenges
Table 17. Common Drugs Use in Ophthalmology Market Restraints
Table 18. Global Common Drugs Use in Ophthalmology Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Common Drugs Use in Ophthalmology Market Share by Players (2016-2021)
Table 20. Global Top Common Drugs Use in Ophthalmology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Common Drugs Use in Ophthalmology as of 2020)
Table 21. Ranking of Global Top Common Drugs Use in Ophthalmology Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Common Drugs Use in Ophthalmology Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Common Drugs Use in Ophthalmology Product Solution and Service
Table 25. Date of Enter into Common Drugs Use in Ophthalmology Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Common Drugs Use in Ophthalmology Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Common Drugs Use in Ophthalmology Revenue Market Share by Type (2016-2021)
Table 29. Global Common Drugs Use in Ophthalmology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Common Drugs Use in Ophthalmology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Common Drugs Use in Ophthalmology Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Common Drugs Use in Ophthalmology Revenue Market Share by Application (2016-2021)
Table 33. Global Common Drugs Use in Ophthalmology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Common Drugs Use in Ophthalmology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Common Drugs Use in Ophthalmology Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Common Drugs Use in Ophthalmology Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Common Drugs Use in Ophthalmology Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Common Drugs Use in Ophthalmology Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Common Drugs Use in Ophthalmology Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Common Drugs Use in Ophthalmology Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Common Drugs Use in Ophthalmology Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Common Drugs Use in Ophthalmology Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Common Drugs Use in Ophthalmology Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Common Drugs Use in Ophthalmology Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Common Drugs Use in Ophthalmology Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Common Drugs Use in Ophthalmology Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Common Drugs Use in Ophthalmology Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Common Drugs Use in Ophthalmology Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Common Drugs Use in Ophthalmology Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Common Drugs Use in Ophthalmology Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Common Drugs Use in Ophthalmology Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Common Drugs Use in Ophthalmology Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Common Drugs Use in Ophthalmology Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Common Drugs Use in Ophthalmology Market Size by Country (2022-2027) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Common Drugs Use in Ophthalmology Product
Table 68. Pfizer Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Common Drugs Use in Ophthalmology Product
Table 73. Novartis Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Bausch Health Company Details
Table 76. Bausch Health Business Overview
Table 77. Bausch Health Common Drugs Use in Ophthalmology Product
Table 78. Bausch Health Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 79. Bausch Health Recent Development
Table 80. Fresenius Company Details
Table 81. Fresenius Business Overview
Table 82. Fresenius Common Drugs Use in Ophthalmology Product
Table 83. Fresenius Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 84. Fresenius Recent Development
Table 85. Teva Pharmaceutical Company Details
Table 86. Teva Pharmaceutical Business Overview
Table 87. Teva Pharmaceutical Common Drugs Use in Ophthalmology Product
Table 88. Teva Pharmaceutical Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 89. Teva Pharmaceutical Recent Development
Table 90. Allergan Company Details
Table 91. Allergan Business Overview
Table 92. Allergan Common Drugs Use in Ophthalmology Product
Table 93. Allergan Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 94. Allergan Recent Development
Table 95. Mylan Company Details
Table 96. Mylan Business Overview
Table 97. Mylan Common Drugs Use in Ophthalmology Product
Table 98. Mylan Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 99. Mylan Recent Development
Table 100. Santen Pharmaceutical Company Details
Table 101. Santen Pharmaceutical Business Overview
Table 102. Santen Pharmaceutical Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 103. Santen Pharmaceutical Recent Development
Table 104. Takeda Company Details
Table 105. Takeda Business Overview
Table 106. Takeda Common Drugs Use in Ophthalmology Product
Table 107. Takeda Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 108. Takeda Recent Development
Table 109. Johnson & Johnson Company Details
Table 110. Johnson & Johnson Business Overview
Table 111. Johnson & Johnson Common Drugs Use in Ophthalmology Product
Table 112. Johnson & Johnson Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 113. Johnson & Johnson Recent Development
Table 114. APOTEX Company Details
Table 115. APOTEX Business Overview
Table 116. APOTEX Common Drugs Use in Ophthalmology Product
Table 117. APOTEX Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 118. APOTEX Recent Development
Table 119. GE Medical Company Details
Table 120. GE Medical Business Overview
Table 121. GE Medical Common Drugs Use in Ophthalmology Product
Table 122. GE Medical Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 123. GE Medical Recent Development
Table 124. Jamp Pharma Company Details
Table 125. Jamp Pharma Business Overview
Table 126. Jamp Pharma Common Drugs Use in Ophthalmology Product
Table 127. Jamp Pharma Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 128. Jamp Pharma Recent Development
Table 129. Senju Pharmaceutical Company Details
Table 130. Senju Pharmaceutical Business Overview
Table 131. Senju Pharmaceutical Common Drugs Use in Ophthalmology Product
Table 132. Senju Pharmaceutical Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 133. Senju Pharmaceutical Recent Development
Table 134. Chongqing Chemical & Pharmaceutical Holding (Group) Company Company Details
Table 135. Chongqing Chemical & Pharmaceutical Holding (Group) Company Business Overview
Table 136. Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Product
Table 137. Chongqing Chemical & Pharmaceutical Holding (Group) Company Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 138. Chongqing Chemical & Pharmaceutical Holding (Group) Company Recent Development
Table 139. Sun Pharmaceutical Company Details
Table 140. Sun Pharmaceutical Business Overview
Table 141. Sun Pharmaceutical Common Drugs Use in Ophthalmology Product
Table 142. Sun Pharmaceutical Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 143. Sun Pharmaceutical Recent Development
Table 144. Taj Pharmaceuticals Company Details
Table 145. Taj Pharmaceuticals Business Overview
Table 146. Taj Pharmaceuticals Common Drugs Use in Ophthalmology Product
Table 147. Taj Pharmaceuticals Revenue in Common Drugs Use in Ophthalmology Business (2016-2021) & (US$ Million)
Table 148. Taj Pharmaceuticals Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Common Drugs Use in Ophthalmology Market Share by Type: 2020 VS 2027
Figure 2. Anti-inflammatory Drugs Features
Figure 3. Anti-infective Drugs Features
Figure 4. Anti-glaucoma Drugs Features
Figure 5. Anti-allergy Drugs Features
Figure 6. Anti-VEGF Agents Features
Figure 7. Others Features
Figure 8. Global Common Drugs Use in Ophthalmology Market Share by Application: 2020 VS 2027
Figure 9. Dry Eye Case Studies
Figure 10. Glaucoma Case Studies
Figure 11. Infection/Inflammation Case Studies
Figure 12. Retinal Disorders Case Studies
Figure 13. Others Case Studies
Figure 14. Common Drugs Use in Ophthalmology Report Years Considered
Figure 15. Global Common Drugs Use in Ophthalmology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Common Drugs Use in Ophthalmology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Common Drugs Use in Ophthalmology Market Share by Regions: 2020 VS 2027
Figure 18. Global Common Drugs Use in Ophthalmology Market Share by Regions (2022-2027)
Figure 19. Global Common Drugs Use in Ophthalmology Market Share by Players in 2020
Figure 20. Global Top Common Drugs Use in Ophthalmology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Common Drugs Use in Ophthalmology as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Common Drugs Use in Ophthalmology Revenue in 2020
Figure 22. Global Common Drugs Use in Ophthalmology Revenue Market Share by Type (2016-2021)
Figure 23. Global Common Drugs Use in Ophthalmology Revenue Market Share by Type (2022-2027)
Figure 24. North America Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Common Drugs Use in Ophthalmology Market Share by Type (2016-2027)
Figure 26. North America Common Drugs Use in Ophthalmology Market Share by Application (2016-2027)
Figure 27. North America Common Drugs Use in Ophthalmology Market Share by Country (2016-2027)
Figure 28. United States Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Common Drugs Use in Ophthalmology Market Share by Type (2016-2027)
Figure 32. Europe Common Drugs Use in Ophthalmology Market Share by Application (2016-2027)
Figure 33. Europe Common Drugs Use in Ophthalmology Market Share by Country (2016-2027)
Figure 34. Germany Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Common Drugs Use in Ophthalmology Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Common Drugs Use in Ophthalmology Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Common Drugs Use in Ophthalmology Market Share by Region (2016-2027)
Figure 44. China Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Common Drugs Use in Ophthalmology Market Share by Type (2016-2027)
Figure 52. Latin America Common Drugs Use in Ophthalmology Market Share by Application (2016-2027)
Figure 53. Latin America Common Drugs Use in Ophthalmology Market Share by Country (2016-2027)
Figure 54. Mexico Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Common Drugs Use in Ophthalmology Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Common Drugs Use in Ophthalmology Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Common Drugs Use in Ophthalmology Market Share by Country (2016-2027)
Figure 60. Turkey Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Common Drugs Use in Ophthalmology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Pfizer Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 65. Bausch Health Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 66. Fresenius Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 67. Teva Pharmaceutical Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 68. Allergan Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 69. Mylan Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 70. Santen Pharmaceutical Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 71. Takeda Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 72. Johnson & Johnson Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 73. APOTEX Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 74. GE Medical Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 75. Jamp Pharma Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 76. Senju Pharmaceutical Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 77. Chongqing Chemical & Pharmaceutical Holding (Group) Company Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 78. Sun Pharmaceutical Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 79. Taj Pharmaceuticals Revenue Growth Rate in Common Drugs Use in Ophthalmology Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…- 世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
- 世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 世界の抗インフルエンザ薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-influenza Drugs Market The global Anti-influenza Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の抗糖尿病薬市場規模・現状・予測（2021年-2027年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…